兆龍互連(300913.SZ):控股股東、實際控制人及董事、高級管理人員自願承諾不減持公司股份
格隆匯12月19日丨兆龍互連(300913.SZ)公佈,近日收到控股股東、實際控制人、公司董事、高級管理人員出具的《關於自願承諾不減持公司股份的承諾函》,公司控股股東浙江兆龍控股有限公司,實際控制人姚金龍先生,董事、高級管理人員姚雲濤先生,董事姚銀龍先生承諾:“自首次公開發行前已發行股份限售股上市流通之日起12個月內,即2023年12月21日至2024年12月20日不以任何形式減持本公司/本人所直接持有的兆龍互連股份,包括承諾期間該部分股份因資本公積轉增、派送股票紅利、配股、增發等事項產生的新增股份。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.